Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells - Test2 - elhamkhani - TriplyDB

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

http://www.wikidata.org/entity/Q28388722

about

PTEN regulation of ERK1/2 signaling in cancer Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling Cysteine (C)-x-C receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cells ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells.Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling ROS-mediated regulation of CXCR4 in cancer.Cysteine (C)-X-C Receptor 4 Regulates NADPH Oxidase-2 During Oxidative Stress in Prostate Cancer Cells.ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.Prostate cancer: the need for biomarkers and new therapeutic targets.The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer.Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer.MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.From prostate to bone: key players in prostate cancer bone metastasis.Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.The oncogenic transcription factor ERG represses the transcription of the tumour suppressor gene PTEN in prostate cancer cells.Advances in prostate cancer research models: From transgenic mice to tumor xenografting models.Overexpressing TPTE2 (TPIP), a homolog of the human tumor suppressor gene PTEN, rescues the abnormal phenotype of the PTEN-/- mutant.

P2860

Q27011088-672C3918-8F75-4831-A926-9BFCBA370DC5 Q33651942-ED546B77-09CA-4659-956F-A00669D6D5DD Q34611859-68DA2B41-C1A6-48B7-B4AF-BC7FC3C8C2F3 Q35185336-2498F9D2-7307-43E2-8350-8C73FBB9CD6D Q35650902-8F9172AE-49A4-422E-89B6-1DCB23C637C0 Q36625600-45ADA482-A3B1-4ABA-94C7-163766137A38 Q36876322-D74D15D3-5AD7-4C60-8A8E-7C1A14C8B05C Q37116576-5A139FD1-CB13-4602-B7D9-B82C0981B996 Q37287538-E876A58F-8632-4E44-BFF5-418D4926C09C Q37373794-B52B4EC0-CF37-4DF9-B9A9-40F20C939A08 Q37457689-1319CA06-215B-4C3A-8DE4-A2DA51FD070C Q37476043-C8973A5F-FB10-4FDE-99F8-20BD709DE174 Q37520184-59874BED-5197-4EBF-90A6-5874EBD95AAE Q37632152-94D77CD7-9005-44B6-A68A-414BD5150E26 Q37970017-213F0FF8-CE6F-41E8-9E1F-000B2050DBF5 Q38819732-509A6B0C-3FF1-4DB0-8D13-308468F77901 Q38932495-201E2CEE-BDFB-4F5F-9C45-E0F948600411 Q39014048-BCD4C2DA-CB6A-46BB-A24B-AEC093EFFE1C Q41493335-320F4956-CC45-40C7-9964-108DB7B08F6A Q41904630-A4A1BD1C-8573-403C-A2B3-10C85BF4070A Q45885573-9ABC1279-72C7-4BD4-8095-874DD20D8D40 Q47102112-E0FB27DE-8571-4F5F-AE3B-9FFF3B0902BD Q55237889-4CB0187D-F563-4AF1-BD72-3704830FAE3F Q55404029-92DB50E8-1FBB-4F98-8ACB-3FE3F6968553

P2860

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

http://www.wikidata.org/entity/Q28388722

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@ast

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@en

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@nl

type

label

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@ast

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@en

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@nl

prefLabel

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@ast

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@en

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@nl

P1433

Q28388722-34F8B3C2-88A3-4081-832C-CCDF07B333E8

P1476

Q28388722-8AA27749-78D7-4A77-8054-1332F8AE5580

P2093

Q28388722-BDBE87CE-B018-4AE9-B458-4AEC6B210701

Q28388722-E1845DA2-E1EE-4C7A-B1AF-82219DDACF51

P2860

Q28388722-03B65EEE-59E9-48CD-9F47-16F8575D34B1

Q28388722-0435DCC9-76DD-488F-A374-51E1DC6200E4

Q28388722-086B5C69-C8DD-449C-91F7-70A02DF0C318

Q28388722-0C1078DC-2AB4-4754-9330-2FE315F5CBEA

Q28388722-11AD3563-B107-4473-A262-66646346F566

Q28388722-11C7AB7B-D763-4BE2-A1AE-5ECB1AFFEE1D

Q28388722-1F6ED05E-130B-4D5F-90E9-C0952FC0A746

Q28388722-2DB71CEC-30E3-4476-8AA9-94BB63F83731

Q28388722-36631E7B-E212-4378-8724-E13F82538281

Q28388722-4C697CD1-2CF3-4738-B050-556199684B34

P304

Q28388722-71693456-A311-45FC-A243-C99609DF48B0

P31

Q28388722-1F67F85C-131C-480A-A80F-30E828860BA5

P3181

Q28388722-54558D79-8C90-4ECC-950A-827904C819DF

P356

Q28388722-3682E3CF-CEEA-4855-B997-7850CD970BFE

P407

Q28388722-333F90DC-AFE2-406A-BD60-4E8AE4D9009B

P433

Q28388722-1CEB32EB-0D18-4D36-9798-6218CBDF561C

P478

Q28388722-EC65A0A6-987A-4BE8-8203-DADB1A736924

P50

Q28388722-D116DC5A-191D-4BF2-B255-93DD43545587

P577

Q28388722-7A634B9B-E2F5-4DE4-B1AD-E021E97C8E24

P698

Q28388722-3063D0A4-3B05-48DB-AC0F-009B200AC419

P932

Q28388722-735F945B-67AB-4F27-9FE7-BB44F91F48AC

P3181

P356

1541-7786.MCR-10-0235

P1433

Molecular Cancer Research

P1476

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

@en

P2093

Mahandranauth A Chetram

http://www.w3.org/2001/XMLSchema#string

Valerie Odero-Marah

http://www.w3.org/2001/XMLSchema#string

P2860

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer

PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis

The role of PTEN in prostate cancer cell tropism to the bone micro-environment.

CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression

P304

90-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4833577

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1541-7786.MCR-10-0235

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Cimona V Hinton

P577

2010-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21076047

http://www.w3.org/2001/XMLSchema#string

P932

3443870

http://www.w3.org/2001/XMLSchema#string